LVTX

LAVA Therapeutics
LVTX

Delisted

LVTX was delisted on the 20th of November, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in LAVA Therapeutics in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 21

Holders
–
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$3.98M
2
-$3.24M
3
-$3.07M
4
S
Sanofi
France
-$2.99M
5
MC
Merck & Co
New Jersey
-$1.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
1
Shay Capital
New York
–
RG
2
Redmile Group
California
–
BCM
3
BML Capital Management
Indiana
–
S
4
Sanofi
France
–
MC
5
Merck & Co
New Jersey
–
GS
6
GTS Securities
New York
–
RC
7
Rangeley Capital
Connecticut
–
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
–
Citadel Advisors
9
Citadel Advisors
Florida
–
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
–
LDNAM
11
Lepercq De Neuflize Asset Management
New York
–
JC
12
JBF Capital
Colorado
–
XT
13
XTX Topco
Cayman Islands
–
UBS Group
14
UBS Group
Switzerland
–
TC
15
Torno Capital
Massachusetts
–
Geode Capital Management
16
Geode Capital Management
Massachusetts
–
EPM
17
Equitec Proprietary Markets
Illinois
–
Jones Financial Companies
18
Jones Financial Companies
Missouri
–
TFGT
19
TS Financial Group (TSFG)
Illinois
–
SS
20
SBI Securities
Japan
–
SWIM
21
Smallwood Wealth Investment Management
New Jersey
–